Alcidion Group Ltd (ASX:ALC) MD/CEO Kate Quirke speaks with Proactive at the ASX Small and Mid Cap Conference - September 2023. The company offers a clinical decision support platform that utilises AI, data and automated workflows to detect emerging patient risks to doctors and nurses. ALC’s technology meets the growing demand in the global healthcare market for digital tools. Quirke says the company has $33.7 million of contracted revenue to be recognised in FY24.
Alcidion with Proactive at ASX Small and Mid Cap Conference
